"Fen-Phen" Information
(fenfluramine, phentermine, dexfenfluramine)
FDA Announces Withdrawal of Fenfluramine and Dexfenfluramine
Since 1997 we have interviewed over 500 potential Fen-Phen clients. We
routinely provide information to these people at no cost. We are happy to
provide you that same information, or to discuss and review your individual
situation with you. The references shown below will lead you to some of the
critical information you need in a review of this area. The source of this
information is the Food and Drug Administration. After completing your review, you can contact us by
(1) printing, filling out, and faxing to us the questionnaire in the upper
left hand corner of this page, (2) calling us toll free at 800-447-6443, or
(3) contacting us by E-mail.
"Fen-Phen" Information (fenfluramine, phentermine, dexfenfluramine) FDA
Announces Withdrawal of Fenfluramine and Dexfenfluramine. With the withdrawal
of fenfluramine and dexfenfluramine from the US market, many people have asked
what they should do if they have taken these drugs. In order to try to provide
guidance, based on the best information known at present, the Centers for
Disease Control and Prevention, the Food and Drug Administration, and the
National Institutes of Health (all components of Department of Health and
Human Services) collaborated with experts within the medical community to
develop interim recommendations for patients. The interim recommendations were
published in the November 14th issue of the Morbidity and Mortality Weekly
Report (MMWR). This updated Fen/Phen information page contains these
recommendations, along with a FDA press release [11/13/97] and a series of
questions and answers about these interim recommendations.
News/Government Reports
We direct you to the following less known
search engines and other resources where up-to-date news reports on the
litigation, the class action, and the 10,000+ lawsuits may be found.
Obviously, we cannot judge how reliable or accurate any one certain
article is, but the source indicates trustworthiness. It is also a good
place to browse for new information.
CNN
News Service Reports on Fen-Phen
U.S.A.
Today News Service
Mealeys
Litigation Report on Fen-Phen/Redux
Center
On Disease Control: Criteria to Determine Injury to Heart
Heart
Information Network: Experts Recommend Echocardiogram
PubMed
(National Library of Medicine)
Class Action Settlement: Official Court
Documents
Warning!!!! We
are directing you to the official site of the Nationwide Class Action,
which has been preliminarily approved by that state court. DO go to
the site. Read the Notices. Read the Settlement Agreement. Look at the
compensation grid. Download and print information from the site. Consider
the pros and cons of being a class member. However, Do NOT (1)
register (either on-line or by calling and leaving your name and address),
(2) file a Claim, (3) Opt Out, or (4) file anything with the class action
or its administrators without first speaking to a lawyer about the issues
and possible results of taking any of these actions.
More
News Articles on the Settlement Than You Ever Wanted to Read
| About Us | Asbestos | Commercial | Fen - Phen | Silicosis | Breast Implants | Location |
  
|
